27. Deutscher Krebskongress
Deutsche Krebsgesellschaft e. V.
22. - 26.03.2006, Berlin
Head and Neck Cancer
Meeting Abstract
(OP239)
[Volltext]
Induction chemotherapy with paclitaxel and cisplatin, followed by accelerated-hyperfractionated radiotherapy in patients with advanced laryngeal and hypopharyngeal cancer – the DeLOS (Deutsche Larynxorganerhaltung-Studiengruppe)-trial
Dietz A, Rudat V, Hoppe F, Pfreundner L, Flentje M[Volltext]
Meeting Abstract
(OP240)
[Volltext]
Recurrence and Survival in Resected Head and Neck Squamous Cell Carcinoma: 10-Year Results of a Randomized Clinical Trial
Steuer-Vogt MK, Fauser C, Bonkowsky V, Ambrosch P, Scholz M, Strutz J[Volltext]
Meeting Abstract
(OP241)
[Volltext]
Quality of life in laryngeal cancer patients: Comparison of total (TL) versus partial laryngectomy (PL) adjusted to tumour stage
Bindewald J, Herrmann E, Wulke C, Dietz A, Schwarz R, Singer S[Volltext]
Meeting Abstract
(OP242)
[Volltext]
Multicentricinvestigation of psychological comorbidity in laryngectomees
Singer S, Dietz A, Meyer A, Wulke C, Oeken J, Klemm E, Kienast U, Kluge A, Heim M, Schwarz R[Volltext]
Meeting Abstract
(OP243)
[Volltext]
TPF chemotherapy regimen in advanced head and neck cancer
Baghi M, Hambek M, Wagenblast J, Gstoettner W, Knecht R[Volltext]
Meeting Abstract
(PO244)
[Volltext]
Expierences in diagnostic and therapy of the Hemangiopericytoma as a rare tumor of the skull base
Koscielny S[Volltext]
Meeting Abstract
(PO245)
[Volltext]
Treatment of Locally Invasive Thyroid Cancer
Roka R, Hermann M, Pramhas M[Volltext]
Meeting Abstract
(PO246)
[Volltext]
Ear, nose and throat cancers: impairments of the patients, modules of rehabilitation, social medicine outcome, and impact on national economics
Rogge H, Passow H[Volltext]
Meeting Abstract
(PO247)
[Volltext]
Results of primary IMRT Radio- and Radio-Chemotherapy in inoperable head and neck cancer patients
Buchali A, Blank E, Franzen A, Keune G, Schmidt M, Huhnt W, Sidow D[Volltext]
Meeting Abstract
(PO248)
[Volltext]
Late toxicities in head and neck cancer patients. Influence of cytoprotection ?
Büntzel J, Glatzel M, Fröhlich D, Gäbert J, Micke O, Mücke R, Kisters K, Schönekaes K, Bruns F[Volltext]
Meeting Abstract
(PO249)
[Volltext]
Are telomerase levels and immunohistochemical hTERT assessment prognostic markers of tumours or tumour margin tissues from head-neck squamous cell carcinomas
Fabricius EM, Gurr U, Khoury R, Wildner GP, Raguse JD[Volltext]
Meeting Abstract
(PO250)
[Volltext]
18FDG-PET as a Marker for Prognosis in Differentiated Thyroid Cancer
Menzel C, Döbert N, Kovacs A, Zaplatnikov K, Welsch M, Grünwald F[Volltext]
Meeting Abstract
(PO251)
[Volltext]
Interstitial brachytherapy in the treatment of relapse of previously irradiated head and neck tumors
Warszawski A, Baumann R, Eckardt A, Stieve M, Karstens JH[Volltext]
Meeting Abstract
(PO252)
[Volltext]
Comparison of Two Radiochemotherapy (RCT) Schedules for Locally Advanced Squamous Cell Head and Neck Cancer
Tribius S, Schneider T, Sheikh-Sarraf M, Schild SE, Alberti W, Rades D[Volltext]
Meeting Abstract
(PO253)
[Volltext]
Ultraradical resection of thyroid carcinoma: surgical heroism or multilation?
Dürsch M, Reingruber B, Hohenberger W[Volltext]
Meeting Abstract
(PO254)
[Volltext]
Improvement of postlaryngectomy esophageal speech rehabilitation after pharyngeal constrictor myotomy
Boghardt J, Kahmann B, Pfaffenroth V, Gutenbrunner C[Volltext]
Meeting Abstract
(PO255)
[Volltext]
Simultaneous radiochemotherapy (RCT) and accelerated comcomitant boost radiotherapy (CBT) in advanced head and neck (H&N) cancer: Long term results and late sequelae
Schüller P, Schäfer U, Micke O, Willich N[Volltext]
